The Effect of Crosin on Expression of Interleukin 6 in Human Glioblastoma Cell Line

Document Type : Original Article (s)

Authors

1 Student, Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran

2 Professor, Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran

3 Assistant Professor, Department of Pharmacology, School of Pharmacy AND Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran

Abstract

Background: Crosin is one of the most important ingredients of saffron (the Iridaceae family) that has been emphasized in Iranian traditional medicine for its anti-inflammatory and anti-tumor effects. Glioblastoma is one of the most malignant cancers resistant to radiation and chemotherapy in adults. The goal of the present study was to investigate the effect crosin on expression of interleukin 6 (IL-6) in human glioblastoma cell line.Methods: Human glioblastoma cell line (1321N1) was purchased from Pasteur Institute of Iran. Cell was grown in Dulbico’s modified essential media (DMEM) supplemented whit 10% fetal bovine serum (FBS). The half-maximal inhibitory concentration (IC50) value of crosin was obtained using MTT assay. Glioblastoma cell line was treated by different concentration of crosin (5, 10, 15 mM/ml) for 24 hours. Then, total RNA was isolated from cells and used for cDNA synthesis. Expression level of IL-6 was assessed using real-time polymerase chain reaction (real-time PCR).Findings: The IC50 value of crosin against 1321N1 cells after 24 hours were determined as 53.3 mMol/ml. Moreover, the expression of IL-6 gene was downregulated by increasing of crosin concentration compare to the control group (P < 0.050).Conclusion: It was observed that crosin inhibited production of IL-6 in glioblastoma cells. In conclusion, the result suggested crosin as a potential therapeutic candidate for neuroinflammation in glioblastoma cancer.

Keywords

References

  1. Pourganji M, Hosseini M, Soukhtanloo M, Zabihi H, Hadjzadeh MA. Protective role of endogenous ovarian hormones against learning and memory impairments and brain tissues oxidative damage induced by lipopolysaccharide. Iran Red Crescent Med J 2014; 16(3): e13954.
  2. Yeung YT, McDonald KL, Grewal T, Munoz L. Interleukins in glioblastoma pathophysiology: Implications for therapy. Br J Pharmacol 2013; 168(3): 591-606.
  3. Saavedra JM. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) 2012; 123(10): 567-90.
  4. Bargi R, Salmani H, Asgharzadeh Yazdi F, Hosseini M. Inflammation and the brain disorders: A review. Shefaye Khatam 2017; 5(3): 68-82. [In Persian].
  5. Snoussi K, Mahfoudh W, Bouaouina N, Ahmed SB, Helal AN, Chouchane L. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 2006; 67(1-2): 13-21.
  6. Shan Y, He X, Song W, Han D, Niu J, Wang J. Role of IL-6 in the invasiveness and prognosis of glioma. Int J Clin Exp Med 2015; 8(6): 9114-20.
  7. Krohn K, Rao MS, Raman NV, Khalilullah M. High-performance thin layer chromatographic analysis of anti-inflammatory triterpenoids from Boswellia serrata Roxb. Phytochem Anal 2001; 12(6): 374-6.
  8. Weissenberger J, Loeffler S, Kappeler A, Kopf M, Lukes A, Afanasieva TA, et al. IL-6 is required for glioma development in a mouse model. Oncogene 2004; 23(19): 3308-16.
  9. Liu Q, Li G, Li R, Shen J, He Q, Deng L, et al. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol 2010; 100(2): 165-76.
  10. Zhang J, Sarkar S, Cua R, Zhou Y, Hader W, Yong VW. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis. Carcinogenesis 2012; 33(2): 312-9.
  11. Liakopoulou-Kyriakides M, Kyriakidis DA. Croscus sativus-biological active constitutents.. Studies in Natural Products Chemistry Bioactive Natural Products 2002; 26, Part G: 293-312.
  12. Gohari AR, Saeidnia S, Mahmoodabadi MK. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn Rev 2013; 7(13): 61-6.
  13. Kamalipour M, Akhondzadeh S. Cardiovascular effects of saffron: An evidence-based review. J Tehran Heart Cent 2011; 6(2): 59-61.
  14. Melnyk JP, Wang S, Marcone MF. Chemical and biological properties of the world's most expensive spice: Saffron. Food Res Int 2010; 43(8): 1981-9.
  15. Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res 2005; 19(11): 997-1000.
  16. Lee BM, Park KK. Beneficial and adverse effects of chemopreventive agents. Mutat Res 2003; 523-524: 265-78.
  17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1-2): 55-63.
  18. Forouzandeh S, Naghsh N, Salimi S, Jahantigh D. Cytotoxic effect of Boswellia serrata hydroalcholic extract on human cervical carcinoma epithelial cell line. Med Lab J 2014; 8(1): 7-13. [In Persian].
  19. Escribano J, Alonso GL, Coca-Prados M, Fernandez JA. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett 1996; 100(1-2): 23-30.
  20. Garcia-Olmo DC, Riese HH, Escribano J, Ontanon J, Fernandez JA, Atienzar M, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): An experimental study in the rat. Nutr Cancer 1999; 35(2): 120-6.
  21. Aung HH, Wang CZ, Ni M, Fishbein A, Mehendale SR, Xie JT, et al. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 2007; 29(3): 175-80.
  22. Ohno Y, Toyoshima Y, Yurino H, Monma N, Xiang H, Sumida K, et al. Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy. Cancer Sci 2017; 108(10): 1959-66.
Journal of Isfahan Medical School
Volume 37, Issue 537 - Serial Number 537
July and August 2019
Pages 903-909

Files

History

  • Receive Date: 26 August 2019
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics